ERYTHROPOIETIC PROTOPORPHYRIA

Clinical trials for ERYTHROPOIETIC PROTOPORPHYRIA explained in plain language.

Never miss a new study

Get alerted when new ERYTHROPOIETIC PROTOPORPHYRIA trials appear

Sign up with your email to follow new studies for ERYTHROPOIETIC PROTOPORPHYRIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 3

New drug aims to give sunlight back to people with debilitating light sensitivity

Disease control ENROLLING_BY_INVITATION

This study is testing the long-term safety and effectiveness of an experimental drug called bitopertin for people with erythropoietic protoporphyria (EPP), a rare disorder that causes severe, painful reactions to sunlight. The research will monitor side effects and see if the dru…

Matched conditions: ERYTHROPOIETIC PROTOPORPHYRIA

Phase: PHASE2, PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

ERYTHROPOIETIC PROTOPORPHYRIA

Get alerted when new ERYTHROPOIETIC PROTOPORPHYRIA trials appear

New drug aims to give sunlight back to people with debilitating light sensitivity